LIVE PULSE
4.8 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.6 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.4 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src2.1 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.7 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.4 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.3 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.3 Paper Examines How First Query Shapes Agentic Deep Search — 1 src1.3 Conformance-Driven Iterative Refinement for Natural-Language to SysMLv2 Translation — 1 src1.3 Neural Operators for Nonlinear Functionals on RKHS — 1 src4.8 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.6 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.4 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src2.1 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.7 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.4 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.3 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.3 Paper Examines How First Query Shapes Agentic Deep Search — 1 src1.3 Conformance-Driven Iterative Refinement for Natural-Language to SysMLv2 Translation — 1 src1.3 Neural Operators for Nonlinear Functionals on RKHS — 1 src
HEATPULSEAI MAGAZINES
FLIP · FOLLOW · SAVE
Log inSign up

lung-fibrosis

topic1 events
papersSEP 9 10:58 UTC

AI-designed lung fibrosis drug linked to slower biological aging in trial

A drug candidate for lung fibrosis that was developed with the help of artificial intelligence produced effects in a study that point to a reduced pace of biological aging. The reported findings come from a single trial and indicate additional effects beyond the compound's intended antifibrotic action. Researchers have not yet established whether these observations translate into clinical benefits for patients.

drug-discovery/ai-biotech/clinical-trial/aging